Development of drugs against cancer is a common cause. Doctors from Tyumen Multidisciplinary Clinical Center “Meditsinsky Gorod” will take part in the project.
The decision was taken after a working visit to Vladimir region where doctors from Tyumen Meditsinsky Gorod got acquainted with the work of the first Rssian International Scientific Center of Cell Biotechnologies Generium that develops new biotechnology-based drugs.
According to Andrey Kudryakov, Chief Medical Officer, CC Meditsinsky Gorod, an agreement with Generium is being prepared to enable participation in clinical trials of drugs already manufactured at that site. Soon joint production at molecular-genetic laboratory of Tyumen Medgorod will be organized. That laboratory will help determine genetic abnormalities in gentic, neurological and other disorders, as well as in cardiovascular diseases. According to Andrey Kudyakov, the time has come for perspective production of drugs for treatment of those disorders, improvement of methods of treatment of oncological, cardiovascular and neurosurgical disorders.